Literature DB >> 11972864

Antisense oligodeoxynucleotides against thrombomodulin suppress the cell growth of lung adenocarcinoma cell line A549.

Masakazu Fujiwara1, Enjing Jin, Mohammad Ghazizadeh, Oichi Kawanami.   

Abstract

Thrombomodulin (TM), an anticoagulant factor on endothelial cells, is known to be expressed in non-endothelial cells as well. In neoplastic cells of lung adenocarcinomas, TM is expressed but its correlation with growth potential has not been studied. As TM expression has a negative correlation with cell proliferation in lung squamous cell carcinomas, we examined its growth effect on lung adenocarcinoma cells of the A549 cell line by inhibiting TM expression with antisense oligodeoxynucleotides (ODN). In the antisense ODN transfected cells, the expression of TM mRNA was decreased to 49% at 12 h and 47% at 24 h, which was in accordance with TM expression at the protein level. By IdU (5-iodo-2'-deoxyuridine) incorporation assay, the growth of A549 cells was found to have decreased to 36% of the control level at 24 h post-transfection. The suppression of cell growth was maintained in a concentration-dependent manner for 48 h after transfection, when the expression of TM started to rebound. In the transfected cells, the G1 phase cell count was reduced to 60.7%, compared with 68.2% in the control transfectants. These results suggest that TM expression may play a suppressive role in the proliferation activity of A549 lung adenocarcinoma cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11972864     DOI: 10.1046/j.1440-1827.2002.01332.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  3 in total

1.  Effect of Thrombomodulin Alfa on Disseminated Intravascular Coagulation in Patients with Lung Cancer.

Authors:  Kentaro Nakano; Kumiya Sugiyama; Hideyuki Satoh; Hajime Arifuku; Takayoshi Fujimatsu; Naruo Yoshida; Hiroyoshi Watanabe; Shingo Tokita; Tomoshige Wakayama; Masamitsu Tatewaki; Ryosuke Souma; Hiroyuki Masuda; Kenya Koyama; Hirokuni Hirata; Yasutsugu Fukushima
Journal:  Intern Med       Date:  2017-07-15       Impact factor: 1.271

2.  Risk factors for disseminated intravascular coagulation in patients with lung cancer.

Authors:  Kentaro Nakano; Kumiya Sugiyama; Hideyuki Satoh; Sadaaki Shiromori; Kei Sugitate; Hajime Arifuku; Naruo Yoshida; Hiroyoshi Watanabe; Shingo Tokita; Tomoshige Wakayama; Masamitsu Tatewaki; Ryosuke Souma; Kenya Koyama; Hirokuni Hirata; Yasutsugu Fukushima
Journal:  Thorac Cancer       Date:  2018-05-31       Impact factor: 3.500

Review 3.  Thrombomodulin and the vascular endothelium: insights into functional, regulatory, and therapeutic aspects.

Authors:  Fiona A Martin; Ronan P Murphy; Philip M Cummins
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-19       Impact factor: 4.733

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.